Literature DB >> 24145137

The 3,7-diazabicyclo[3.3.1]nonane scaffold for subtype selective nicotinic acetylcholine receptor ligands. Part 2: carboxamide derivatives with different spacer motifs.

Christoph Eibl1, Lenka Munoz, Isabelle Tomassoli, Clare Stokes, Roger L Papke, Daniela Gündisch.   

Abstract

3,7-Diazabicyclo[3.3.1]nonane (bispidine) based nicotinic acetylcholine receptor (nAChR) ligands have been synthesized and evaluated for nAChRs interaction. Diverse spacer motifs were incorporated between the hydrogen bond acceptor (HBA) part and a variety of substituted (hetero)aryl moieties. Bispidine carboxamides bearing spacer motifs often showed high affinity in the low nanomolar range and selectivity for the α4β2(∗) nAChR. Compounds 15, 25, and 47 with Ki values of about 1 nM displayed the highest affinities for α4β2(∗) nAChR. All evaluated compounds are partial agonists or antagonists at α4β2(∗), with reduced or no effects on α3β4(∗) with the exception of compound 15 (agonist), and reduced or no effect at α7 and muscle subtypes.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  1,2-dimethoxyethane; 3,7-Diazabicyclo[3.3.1]nonane; 4-(2-hydroxyethyl)piperazine-1-ethanesulfonic acid; 4-(dimethylamino)pyridine; BBB; Bispidine; CD(3)OD; CDCl(3); CH(2)Cl(2); CNS; Cytisine; D(2)O; DCC; DMAP; DME; DMF; Et(2)O; Et(3)N; EtOAc; HBA; HCl; HEPES; HEPES-buffered salt solution; HSS; K(2)CO(3); KBr; KMnO(4); KOH; MeCN; MeI; MeOH; MgSO(4); N,N-dimethylformamide; N,N′-dicyclohexylcarbodiimide; NaHCO(3); NaOH; Nicotinic acetylcholine receptor; PE; PEI; Pd/C; Ro5; Structure–activity relationship; THF; TPSA; TRIS; ZnBr(2); acetonitrile; blood–brain barrier; central nervous system; deuterium oxide; deuterochloroform; dichloromethane; diethyl ether; ethyl acetate; hydrogen bond acceptor; hydrogen chloride; iodomethane; magnesium sulfate; methanol; nAChR; nicotinic acetylcholine receptor; palladium on activated charcoal; petroleum ether; poly(ethyleneimine); potassium bromide; potassium carbonate; potassium hydroxide; potassium permanganate; rule of five; sodium hydrogen carbonate; sodium hydroxide; tetradeuteromethanol; tetrahydrofuran; topological polar surface area; tri(hydroxymethyl)aminomethane; triethylamine; zinc bromide

Mesh:

Substances:

Year:  2013        PMID: 24145137      PMCID: PMC4519236          DOI: 10.1016/j.bmc.2013.09.060

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  18 in total

1.  High affinity binding of [3H]epibatidine to rat brain membranes.

Authors:  D Gnädisch; E D London; P Terry; G R Hill; A G Mukhin
Journal:  Neuroreport       Date:  1999-06-03       Impact factor: 1.837

2.  Syntheses and evaluation of halogenated cytisine derivatives and of bioisosteric thiocytisine as potent and selective nAChR ligands.

Authors:  P Imming; P Klaperski; M T Stubbs; G Seitz; D Gündisch
Journal:  Eur J Med Chem       Date:  2001-04       Impact factor: 6.514

3.  Differential modulation of brain nicotinic acetylcholine receptor function by cytisine, varenicline, and two novel bispidine compounds: emergent properties of a hybrid molecule.

Authors:  Can Peng; Clare Stokes; Yann S Mineur; Marina R Picciotto; Chengju Tian; Christoph Eibl; Isabelle Tomassoli; Daniela Guendisch; Roger L Papke
Journal:  J Pharmacol Exp Ther       Date:  2013-08-19       Impact factor: 4.030

Review 4.  Naturally-expressed nicotinic acetylcholine receptor subtypes.

Authors:  Jie Wu; Ronald J Lukas
Journal:  Biochem Pharmacol       Date:  2011-07-20       Impact factor: 5.858

5.  5-Iodo-A-85380, an alpha4beta2 subtype-selective ligand for nicotinic acetylcholine receptors.

Authors:  A G Mukhin; D Gündisch; A G Horti; A O Koren; G Tamagnan; A S Kimes; J Chambers; D B Vaupel; S L King; M R Picciotto; R B Innis; E D London
Journal:  Mol Pharmacol       Date:  2000-03       Impact factor: 4.436

6.  Working with OpusXpress: methods for high volume oocyte experiments.

Authors:  Roger L Papke; Clare Stokes
Journal:  Methods       Date:  2010-01-18       Impact factor: 3.608

7.  Novel nicotinic acetylcholine receptor agonists containing carbonyl moiety as a hydrogen bond acceptor.

Authors:  Anatoly A Mazurov; David C Kombo; Srinivasa Akireddy; Srinivasa Murthy; Terry A Hauser; Kristen G Jordan; Gregory J Gatto; Daniel Yohannes
Journal:  Bioorg Med Chem Lett       Date:  2013-05-01       Impact factor: 2.823

8.  Conservation within the RIC-3 gene family. Effectors of mammalian nicotinic acetylcholine receptor expression.

Authors:  Sarah Halevi; Lina Yassin; Margalit Eshel; Francisco Sala; Salvador Sala; Manuel Criado; Millet Treinin
Journal:  J Biol Chem       Date:  2003-06-23       Impact factor: 5.157

9.  Comparative pharmacology of rat and human alpha7 nAChR conducted with net charge analysis.

Authors:  Roger L Papke; Julia K Porter Papke
Journal:  Br J Pharmacol       Date:  2002-09       Impact factor: 8.739

10.  Knowledge-Based, Central Nervous System (CNS) Lead Selection and Lead Optimization for CNS Drug Discovery.

Authors:  Arup K Ghose; Torsten Herbertz; Robert L Hudkins; Bruce D Dorsey; John P Mallamo
Journal:  ACS Chem Neurosci       Date:  2011-11-02       Impact factor: 4.418

View more
  2 in total

1.  The twin drug approach for novel nicotinic acetylcholine receptor ligands.

Authors:  Isabelle Tomassoli; Daniela Gündisch
Journal:  Bioorg Med Chem       Date:  2015-06-20       Impact factor: 3.641

2.  Palladium(II)-Catalysed Aminocarbonylation of Terminal Alkynes for the Synthesis of 2-Ynamides: Addressing the Challenges of Solvents and Gas Mixtures.

Authors:  N Louise Hughes; Clare L Brown; Andrew A Irwin; Qun Cao; Mark J Muldoon
Journal:  ChemSusChem       Date:  2017-01-23       Impact factor: 8.928

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.